BR9600147A - Purin-6-onas 2,9-DI-substituidas processo para sua preparação medicamentos e uso - Google Patents

Purin-6-onas 2,9-DI-substituidas processo para sua preparação medicamentos e uso

Info

Publication number
BR9600147A
BR9600147A BR9600147A BR9600147A BR9600147A BR 9600147 A BR9600147 A BR 9600147A BR 9600147 A BR9600147 A BR 9600147A BR 9600147 A BR9600147 A BR 9600147A BR 9600147 A BR9600147 A BR 9600147A
Authority
BR
Brazil
Prior art keywords
purin
ones
preparation
medication use
substituted process
Prior art date
Application number
BR9600147A
Other languages
English (en)
Inventor
Ulrich Niewoehner
Erwin Bischoff
Helmuth Schuetz
Elisabeth Perzborn
Matthias Schramm
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BR9600147A publication Critical patent/BR9600147A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
BR9600147A 1995-01-19 1996-01-18 Purin-6-onas 2,9-DI-substituidas processo para sua preparação medicamentos e uso BR9600147A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19501482A DE19501482A1 (de) 1995-01-19 1995-01-19 2,9-disubstituierte Purin-6-one

Publications (1)

Publication Number Publication Date
BR9600147A true BR9600147A (pt) 1998-01-06

Family

ID=7751830

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9600147A BR9600147A (pt) 1995-01-19 1996-01-18 Purin-6-onas 2,9-DI-substituidas processo para sua preparação medicamentos e uso

Country Status (31)

Country Link
US (1) US5861404A (pt)
EP (1) EP0722944A1 (pt)
JP (1) JPH08231545A (pt)
KR (1) KR960029334A (pt)
CN (1) CN1135485A (pt)
AR (1) AR002953A1 (pt)
AU (1) AU4097996A (pt)
BG (1) BG61728B1 (pt)
BR (1) BR9600147A (pt)
CA (1) CA2167353A1 (pt)
CO (1) CO4700523A1 (pt)
CZ (1) CZ16696A3 (pt)
DE (1) DE19501482A1 (pt)
EE (1) EE9600018A (pt)
FI (1) FI960225A (pt)
HR (1) HRP960007A2 (pt)
HU (1) HUP9600106A3 (pt)
IL (1) IL116769A (pt)
MA (1) MA23778A1 (pt)
NO (1) NO960223L (pt)
NZ (1) NZ280830A (pt)
PE (1) PE64996A1 (pt)
PL (1) PL312354A1 (pt)
SG (1) SG50401A1 (pt)
SK (1) SK8096A3 (pt)
SV (1) SV1996000006A (pt)
TN (2) TNSN96006A1 (pt)
TR (1) TR199600028A2 (pt)
TW (1) TW314519B (pt)
YU (1) YU1396A (pt)
ZA (1) ZA96398B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19529102A1 (de) * 1995-08-08 1997-02-13 Kummer Horst Dieter Verwendung von PDE-Inhibitoren bei der Behandlung von Harnblasenerkrankungen
US5824669A (en) * 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
US5958926A (en) 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
USRE37234E1 (en) 1996-11-01 2001-06-19 Nitromed, Inc. Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
CA2295811A1 (en) * 1997-07-15 1999-01-20 Japan Energy Corporation Novel purine derivatives and their use as medicines
DE69824632T2 (de) 1997-11-12 2005-06-09 Mitsubishi Chemical Corp. Purinderivate und medikamente, welche dieselben als aktiven bestandteil enthalten
ATE242775T1 (de) * 1998-01-05 2003-06-15 Eisai Co Ltd Purinderivate und antagonisten des adenosin-a2- rezeptors, welche zur vorsorge oder heilung von diabetes dienen
US6124303A (en) * 1998-09-11 2000-09-26 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones
US6268372B1 (en) 1998-09-11 2001-07-31 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones
WO2000068231A1 (fr) * 1999-05-11 2000-11-16 Mitsubishi Chemical Corporation Dihydrate derive de purine, medicaments le contenant comme principe actif et intermediaire utilise dans sa preparation
GB9924020D0 (en) 1999-10-11 1999-12-15 Pfizer Ltd Pharmaceutically active compounds
US7501409B2 (en) * 2000-09-06 2009-03-10 Mitsubishi Tanabe Pharma Corporation Preparations for oral administration
NZ527585A (en) * 2001-02-15 2005-04-29 Tanabe Seiyaku Co Tablets quickly disintegrated in oral cavity
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
US7893101B2 (en) 2002-03-20 2011-02-22 Celgene Corporation Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
US7276529B2 (en) 2002-03-20 2007-10-02 Celgene Corporation Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
US6962940B2 (en) 2002-03-20 2005-11-08 Celgene Corporation (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
US7208516B2 (en) 2002-03-20 2007-04-24 Celgene Corporation Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
CN102742513A (zh) * 2012-07-17 2012-10-24 南京熊猫机电制造有限公司 一种喂食栏装置
ES2749433T3 (es) 2014-06-23 2020-03-20 Celgene Corp Apremilast para el tratamiento de una enfermedad hepática o una anomalía de la función hepática
US11198699B2 (en) 2019-04-02 2021-12-14 Aligos Therapeutics, Inc. Compounds targeting PRMT5

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
IL76546A (en) * 1984-10-12 1988-12-30 Warner Lambert Co 9-(heteroarylalkyl)-6-purine(thi)one derivatives,their preparation and pharmaceutical compositions containing them
GB9213623D0 (en) * 1992-06-26 1992-08-12 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
TNSN96006A1 (fr) 2005-03-15
TNSN96007A1 (fr) 2005-03-15
SK8096A3 (en) 1996-08-07
YU1396A (sh) 1999-03-04
MA23778A1 (fr) 1996-10-01
EE9600018A (et) 1996-08-15
TR199600028A2 (tr) 1996-08-21
KR960029334A (ko) 1996-08-17
PE64996A1 (es) 1997-03-09
JPH08231545A (ja) 1996-09-10
EP0722944A1 (de) 1996-07-24
HUP9600106A3 (en) 1998-04-28
BG61728B1 (bg) 1998-04-30
ZA96398B (en) 1996-08-28
SG50401A1 (en) 1998-07-20
CN1135485A (zh) 1996-11-13
FI960225A0 (fi) 1996-01-17
IL116769A0 (en) 1996-05-14
NO960223L (no) 1996-07-22
AR002953A1 (es) 1998-05-27
AU4097996A (en) 1996-07-25
PL312354A1 (en) 1996-07-22
NZ280830A (en) 1998-04-27
HUP9600106A2 (en) 1997-05-28
HRP960007A2 (en) 1998-02-28
FI960225A (fi) 1996-07-20
HU9600106D0 (en) 1996-03-28
NO960223D0 (no) 1996-01-18
US5861404A (en) 1999-01-19
BG100292A (bg) 1996-07-31
TW314519B (pt) 1997-09-01
CA2167353A1 (en) 1996-07-20
CO4700523A1 (es) 1998-12-29
DE19501482A1 (de) 1996-07-25
CZ16696A3 (en) 1996-08-14
SV1996000006A (es) 1996-10-29
IL116769A (en) 1998-12-06

Similar Documents

Publication Publication Date Title
BR9600148A (pt) Quinazolinonas 2,8-dissubstituídas processo para sua preparação medicamentos e uso
BR9600147A (pt) Purin-6-onas 2,9-DI-substituidas processo para sua preparação medicamentos e uso
BR9601093A (pt) Pirido(3,2-E)pirazinoas processo para sua preparação medicamentos processo para sua preparação e utilização
BR9612135A (pt) Taxóides processo para sua preparação e composiç o farmacêutica
BR9200951A (pt) Compostos, processo para sua producao,preparacoes farmaceuticas e uso
BR9504509A (pt) Composto processo para sua preparaçao e formulaçao farmaceûtica
BR9505940A (pt) Comprimido mastigável e processo para sua preparação
BR9000116A (pt) Alfa-diazo-beta-cetoester polifuncional,processo para sua preparacao e sua utilizacao
BR9408463A (pt) Novos derivados de ginkgolide e processo para sua preparação
BR9605354A (pt) Composto composição farmacêutica processo para a produção do composto e uso
BR9610180A (pt) Composição líquida autodepositante e processo para sua preparação
BR9402424A (pt) Compostos apresentando grupos amino terciário, processo para a sua preparação e sua utilização
BR9404809A (pt) Composto, uso, formulação farmacêutica e processo para preparar um composto
BR9601275A (pt) Compostos processo para sua preparação medicamentos preparação farmacêutica processo para sua produção e uso
BR9712058B1 (pt) formulações para uso de ivermectina, processo para sua preparação e uso.
BR9602983A (pt) Gel e processo para sua preparação
BR9600149A (pt) 2-(2-N-alcoxifenil)-purin-6-onas 9-substituídas processo para sua preparação medicamantos e uso
BR9303456A (pt) Compostos,processo para sua preparacao,medicamentos,processo para sua preparacao e emprego
BR9206950A (pt) Composição farmacêutica e processo para sua preparação
BR9204547A (pt) Hidroxipiridoncarboxamidas,processo de sua preparacao e aplicacao
BR9206784A (pt) Copolímero bloco de aramida e processo para sua preparação
BR9600778A (pt) Benzenossulfoniluréia e - tiouréla substituida processo para sua preparação seu uso e medicamento
BR9602025A (pt) Composto composição farmacêutica uso e processo para a preparação de um composto
BR9500671A (pt) Veículos para vernizes,processo para sua preparação e uso
BR9600779A (pt) Benzenossulfoniluréias e -tioréias substituidas processo para sua preparação uso e medicamento

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
B11T Dismissal of application maintained [chapter 11.20 patent gazette]